OS Therapies Applauds Reauthorization of Pediatric Priority Review Voucher Program for Osteosarcoma Therapies
OS Therapies Inc. (NYSE:OSTX) NEW YORK, NY, UNITED STATES, February 6, 2026 /EINPresswire.com/ -- OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in listeria-based cancer …